Overview

The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and impact of intravenous ketamine or sublingual 30% glucose as sedation drugs used in preterm premature babies during the LISA procedure. The second goal is to compare the frequency of complications during LISA with both premedication regimens.
Phase:
Phase 1
Details
Lead Sponsor:
Medical University of Warsaw
Treatments:
Ketamine